Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Plos Pathogens|October 28, 2024
Balancing acts: The posttranslational modification tightrope of flavivirus replicationRuthMabel Boytz, Maudry Laurent-Rolle
Npj Viruses|October 7, 2024
Flaviviruses manipulate mitochondrial processes to evade the innate immune responseRuthMabel Boytz, Kadiatou Keita, Joanna B Pawlak, et al.
Viruses|February 24, 2024
Comprehensive Assessment of Inactivation Methods for Madariaga VirusRuthMabel Boytz, Kadiatou Keita, Joanna B Pawlak, et al.
Plos One|September 30, 2024
A suboptimal OCT4-SOX2 binding site facilitates the naïve-state specific function of a Klf4 enhancerJack B Waite, RuthMabel Boytz, Alexis R Traeger, et al.
Viruses|January 21, 2023
Inactivation of Ebola Virus and SARS-CoV-2 in Cell Culture Supernatants and Cell Pellets by Gamma IrradiationRuthMabel Boytz, Scott Seitz, Emily Gaudiano, et al.
Viruses|September 23, 2022
CAPG Is Required for Ebola Virus Infection by Controlling Virus Egress from Infected CellsHiroyuki Mori, James P Connell, Callie J Donahue, et al.
Journal of Molecular Biology|April 11, 2022
Development of Monoclonal Antibodies to Detect for SARS-CoV-2 ProteinsNawneet Mishra, Joan Teyra, RuthMabel Boytz, et al.
The Journal of Clinical Investigation|March 30, 2021
B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skinEmily S Ford, Anton M Sholukh, RuthMabel Boytz, et al.
Data in Brief|July 5, 2022
Monoclonal antibodies binding data for SARS-CoV-2 proteinsNawneet Mishra, Joan Teyra, RuthMabel Boytz, et al.
Antiviral Research|August 30, 2022
Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19James F Demarest, Maryline Kienle, RuthMabel Boytz, et al.
Pageof 2